Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial

被引：40

作者：

Cooper, Mark E. ^{[1
]}

Inzucchi, Silvio E. ^{[2
]}

Zinman, Bernard ^{[3
]}

Hantel, Stefan ^{[4
]}

von Eynatten, Maximilian ^{[5
]}

Wanner, Christoph ^{[6
]}

Koitka-Weber, Audrey ^{[1
,5
,6
]}

机构：

[1] Monash Univ, Cent Clin Sch, Dept Diabet, 99 Commercial Rd, Melbourne, Vic 3004, Australia

[2] Yale Sch Med, Sect Endocrinol, New Haven, CT USA

[3] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada

[4] Boehringer Ingelheim Int GmbH, Biberach, Germany

[5] Boehringer Ingelheim Int GmbH, Ingelheim, Germany

[6] Wurzburg Univ Clin, Dept Med, Wurzburg, Germany

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2019年 / 74卷 / 05期

关键词：

DISEASE; MORTALITY;

D O I：

10.1053/j.ajkd.2019.03.432

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：713 / 715

页数：4

共 8 条

[1] Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014 [J].

Afkarian, Maryam ;

Zelnick, Leila R. ;

Hall, Yoshio N. ;

Heagerty, Patrick J. ;

Tuttle, Katherine ;

Weiss, Noel S. ;

de Boer, Ian H. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (06) :602-610

[2] Kidney Disease and Increased Mortality Risk in Type 2 Diabetes [J].

Afkarian, Maryam ;

Sachs, Michael C. ;

Kestenbaum, Bryan ;

Hirsch, Irl B. ;

Tuttle, Katherine R. ;

Hinnmelfarb, Jonathan ;

de Boer, Ian H. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (02) :302-308

[3] Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial [J].

Cherney, David Z. I. ;

Zinman, Bernard ;

Inzucchi, Silvio E. ;

Koitka-Weber, Audrey ;

Mattheus, Michaela ;

von Eynatten, Maximilian ;

Wanner, Christoph .

LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (08) :610-621

[4] Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects [J].

Heerspink, Hiddo J. L. ;

Desai, Mehul ;

Jardine, Meg ;

Balis, Dainius ;

Meininger, Gary ;

Perkovic, Vlado .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (01) :368-375

[5] Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes [J].

Molitch, Mark E. ;

Adler, Amanda I. ;

Flyvbjerg, Allan ;

Nelson, Robert G. ;

So, Wing-Yee ;

Wanner, Christoph ;

Kasiske, Bertram L. ;

Wheeler, David C. ;

de Zeeuw, Dick ;

Mogensen, Carl E. .

KIDNEY INTERNATIONAL, 2015, 87 (01) :20-30

[6] The effect of RAAS blockade on the progression of diabetic nephropathy [J].

Roscioni, Sara S. ;

Heerspink, Hiddo J. Lambers ;

de Zeeuw, Dick .

NATURE REVIEWS NEPHROLOGY, 2014, 10 (02) :77-87

[7]

Wanner C, 2016, NEW ENGL J MED, V375, P1801, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]

[8] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].

Zinman, Bernard ;

Wanner, Christoph ;

Lachin, John M. ;

Fitchett, David ;

Bluhmki, Erich ;

Hantel, Stefan ;

Mattheus, Michaela ;

Devins, Theresa ;

Johansen, Odd Erik ;

Woerle, Hans J. ;

Broedl, Uli C. ;

Inzucchi, Silvio E. ;

Aizenberg, D. ;

Ulla, M. ;

Waitman, J. ;

De Loredo, L. ;

Farias, J. ;

Fideleff, H. ;

Lagrutta, M. ;

Maldonado, N. ;

Colombo, H. ;

Ferre Pacora, F. ;

Wasserman, A. ;

Maffei, L. ;

Lehman, R. ;

Selvanayagam, J. ;

d'Emden, M. ;

Fasching, P. ;

Paulweber, B. ;

Toplak, H. ;

Luger, A. ;

Drexel, H. ;

Prager, R. ;

Schnack, C. ;

Schernthaner, G. ;

Fliesser-Goerzer, E. ;

Kaser, S. ;

Scheen, A. ;

Van Gaal, L. ;

Hollanders, G. ;

Kockaerts, Y. ;

Capiau, L. ;

Chachati, A. ;

Persu, A. ;

Hermans, M. ;

Vantroyen, D. ;

Vercammen, C. ;

Van de Borne, P. ;

Mathieu, C. ;

Benhalima, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) :2117-2128

← 1 →